00000nam 2200000zi 4500 9.919196 CaOODSP 20230420082429 m o d f cr mn||||||||| 230116e202302 onc ob f000 0 eng d 9780660471129 CaOODSP eng rda CaOODSP n-cn--- y2y2 HP40-331/2023E-PDF Nirmatrelvir/ritonavir implementation in Canada : summary evaluation report : January to August 2022. Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, February 2023. ©2023 1 online resource (iv, 36 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Mise en œuvre du nirmatrelvir/ritonavir au Canada : rapport d'évaluation sommaire : de janvier à août 2022. "Pub.: 220700." Includes bibliographical references. COVID-19 (Disease) Treatment Canada Evaluation. Antiviral agents Therapeutic use Canada Evaluation. Public Health Agency of Canada, issuing body. Mise en œuvre du nirmatrelvir/ritonavir au Canada : (CaOODSP)9.919197 PDF 399 KB https://publications.gc.ca/collections/collection_2023/aspc-phac/HP40-331-2023-eng.pdf 220700